The expression of several glycolytic enzymes (GLUT1, HK2, and LDHA) and their contribution to the promotion of ovarian cancer were assessed in a study by Xintaropoulou et al. This study also demonstrated that ovarian cancer proliferation and the growth of cells were decreased when the glycolytic cycle was inhibited using several glycolytic inhibitors [41]. The gene discussed is SLC2A1; the disease is ovarian cancer.